Target intelligence / Profile preview

Heat shock protein X (alpha-crystallin homolog) (HspX)

Target
HspX
Molecular classification
Small heat shock protein, HSP20 family, Chaperone protein, Stress protein
01

Overview

Heat shock protein X (HspX), also known as alpha-crystallin homolog or Rv2031c, is a small heat shock protein (about 16 kDa) from Mycobacterium tuberculosis critical for bacterial survival under hypoxic (low oxygen) and latent states[1][5][6]. HspX acts as a molecular chaperone, maintaining protein folding and preventing aggregation during stress[1][3][6]. It is highly induced in hypoxic conditions regulated by the DosR regulon, localized in various cellular compartments (including membrane and cytosol)[6], and is an immunodominant antigen recognized by tuberculosis patient sera, making it a key biomarker and vaccine target[2][4][6]. Deletion or overexpression in M. tuberculosis affects bacterial growth dynamics and persistence, demonstrating its regulatory role in the latent phase[1][5].

Other names
16 kDa antigen14 kDa antigenHSP 16.3alpha-crystallinacrRv2031c
02

Mechanism of action

Antigen for vaccine development (stimulates immune response); Induction of both humoral and cell-mediated immunity (as vaccine antigen)[4].

03

Biological functions

Maintenance of viability under stress and hypoxiaRegulation of latency in Mycobacterium tuberculosisChaperone activity (protein folding, preventing aggregation)Immune system target (antigenic stimulus)
04

Disease associations

Infection (specifically tuberculosis)Latency and persistence in Mycobacterium tuberculosis
05

Safety considerations

None specifically reported for direct targetingVariable expression during different infection phasesPotential for false negatives/positives in diagnostic use due to individual immune variability[2]
06

Interacting drugs

No direct small-molecule drugs identified, but used as an antigen in vaccine design and serodiagnostics
07

Biomarkers

Biomarker for latent or active Mycobacterium tuberculosis infection (serodiagnostics)[2][6]

Beyond the preview

Go deeper on Heat shock protein X (alpha-crystallin homolog) (HspX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein X (alpha-crystallin homolog) (HspX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call